Concepts (222)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Sepsis | 6 | 2019 | 3517 | 0.93 | Why? |
| Syndecan-2 | 1 | 2018 | 4 | 0.78 | Why? |
| Acute Lung Injury | 2 | 2018 | 904 | 0.76 | Why? |
| Prone Position | 5 | 2021 | 1861 | 0.74 | Why? |
| Mesenchymal Stem Cell Transplantation | 3 | 2020 | 1322 | 0.71 | Why? |
| Escherichia coli Infections | 2 | 2018 | 348 | 0.70 | Why? |
| Drug Therapy | 1 | 2020 | 280 | 0.69 | Why? |
| Ventilator Weaning | 2 | 2019 | 536 | 0.64 | Why? |
| Waste Management | 1 | 2020 | 240 | 0.61 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2018 | 260 | 0.57 | Why? |
| Respiratory Insufficiency | 7 | 2021 | 7301 | 0.57 | Why? |
| Blood Gas Analysis | 1 | 2017 | 893 | 0.53 | Why? |
| Respiration, Artificial | 17 | 2021 | 22116 | 0.51 | Why? |
| Developed Countries | 1 | 2017 | 500 | 0.50 | Why? |
| Stem Cell Transplantation | 1 | 2017 | 531 | 0.47 | Why? |
| Population Health | 1 | 2018 | 504 | 0.46 | Why? |
| Ventilators, Mechanical | 2 | 2020 | 2193 | 0.41 | Why? |
| Lung Compliance | 2 | 2021 | 243 | 0.39 | Why? |
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 1510 | 0.38 | Why? |
| Positive-Pressure Respiration | 1 | 2017 | 1160 | 0.37 | Why? |
| Shock, Septic | 1 | 2019 | 1313 | 0.37 | Why? |
| Income | 1 | 2017 | 1564 | 0.34 | Why? |
| Biomedical Research | 3 | 2018 | 5270 | 0.34 | Why? |
| Critical Care | 4 | 2021 | 14081 | 0.32 | Why? |
| Patient Positioning | 3 | 2021 | 1505 | 0.30 | Why? |
| Developing Countries | 2 | 2018 | 4283 | 0.28 | Why? |
| Research Design | 2 | 2018 | 5830 | 0.27 | Why? |
| Cell- and Tissue-Based Therapy | 2 | 2018 | 422 | 0.26 | Why? |
| Ireland | 4 | 2021 | 1456 | 0.25 | Why? |
| Intensive Care Units | 11 | 2021 | 29594 | 0.25 | Why? |
| Hypoxia | 4 | 2021 | 3626 | 0.23 | Why? |
| Radiography, Thoracic | 2 | 2018 | 5486 | 0.22 | Why? |
| Trypsin Inhibitors | 1 | 2020 | 38 | 0.22 | Why? |
| Rats, Sprague-Dawley | 3 | 2018 | 987 | 0.22 | Why? |
| Citrulline | 1 | 2020 | 36 | 0.22 | Why? |
| Shiitake Mushrooms | 1 | 2020 | 13 | 0.21 | Why? |
| Mobile Applications | 3 | 2021 | 3032 | 0.21 | Why? |
| Rats | 2 | 2018 | 2764 | 0.20 | Why? |
| Models, Biological | 1 | 2017 | 4907 | 0.20 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2020 | 229 | 0.19 | Why? |
| U937 Cells | 1 | 2018 | 77 | 0.19 | Why? |
| Humans | 53 | 2021 | 930598 | 0.18 | Why? |
| Pneumonia | 2 | 2019 | 5652 | 0.18 | Why? |
| Peptides, Cyclic | 1 | 2020 | 223 | 0.18 | Why? |
| Brachial Plexus Block | 1 | 2017 | 25 | 0.18 | Why? |
| NADPH Oxidase 2 | 1 | 2018 | 58 | 0.18 | Why? |
| alpha 1-Antitrypsin | 1 | 2021 | 264 | 0.18 | Why? |
| Interleukin-7 | 1 | 2019 | 148 | 0.17 | Why? |
| Analgesia, Obstetrical | 1 | 2018 | 69 | 0.17 | Why? |
| Shoulder | 1 | 2017 | 96 | 0.17 | Why? |
| Heparin | 2 | 2021 | 2600 | 0.17 | Why? |
| Bone Marrow Cells | 1 | 2018 | 186 | 0.17 | Why? |
| Fitness Trackers | 1 | 2018 | 120 | 0.16 | Why? |
| Berlin | 1 | 2017 | 283 | 0.16 | Why? |
| Pneumonia, Viral | 11 | 2020 | 243684 | 0.16 | Why? |
| Coronavirus Infections | 11 | 2020 | 253789 | 0.16 | Why? |
| Epithelium | 1 | 2018 | 330 | 0.16 | Why? |
| Nebulizers and Vaporizers | 1 | 2020 | 497 | 0.16 | Why? |
| Prospective Studies | 13 | 2021 | 43301 | 0.16 | Why? |
| International Cooperation | 2 | 2020 | 3436 | 0.15 | Why? |
| Glycoproteins | 1 | 2020 | 615 | 0.15 | Why? |
| Laryngoscopes | 1 | 2017 | 121 | 0.14 | Why? |
| Bone Marrow | 1 | 2018 | 492 | 0.14 | Why? |
| Umbilical Cord | 1 | 2017 | 358 | 0.14 | Why? |
| Pyridones | 1 | 2020 | 738 | 0.14 | Why? |
| Geography, Medical | 1 | 2017 | 537 | 0.14 | Why? |
| Pain Measurement | 1 | 2017 | 533 | 0.14 | Why? |
| Steroids | 1 | 2020 | 904 | 0.14 | Why? |
| Ascorbic Acid | 1 | 2020 | 676 | 0.13 | Why? |
| Macrophages, Alveolar | 1 | 2018 | 668 | 0.13 | Why? |
| Anesthesia, Conduction | 1 | 2018 | 235 | 0.13 | Why? |
| Pain, Postoperative | 1 | 2017 | 289 | 0.13 | Why? |
| Pulmonary Medicine | 1 | 2020 | 706 | 0.13 | Why? |
| Walking | 1 | 2018 | 442 | 0.13 | Why? |
| Databases, Factual | 2 | 2019 | 6248 | 0.13 | Why? |
| Adipose Tissue | 1 | 2018 | 612 | 0.12 | Why? |
| Randomized Controlled Trials as Topic | 7 | 2021 | 10649 | 0.12 | Why? |
| Advisory Committees | 1 | 2020 | 1418 | 0.12 | Why? |
| Patient Outcome Assessment | 1 | 2017 | 707 | 0.12 | Why? |
| Continuous Positive Airway Pressure | 2 | 2021 | 1187 | 0.12 | Why? |
| A549 Cells | 1 | 2018 | 2066 | 0.12 | Why? |
| Pyrimidines | 1 | 2020 | 1557 | 0.12 | Why? |
| Reactive Oxygen Species | 1 | 2018 | 1136 | 0.12 | Why? |
| Wakefulness | 3 | 2021 | 598 | 0.11 | Why? |
| Checklist | 1 | 2017 | 714 | 0.11 | Why? |
| Hospital Mortality | 4 | 2019 | 22087 | 0.11 | Why? |
| Evidence-Based Practice | 1 | 2017 | 693 | 0.11 | Why? |
| Pandemics | 14 | 2021 | 389249 | 0.11 | Why? |
| Education, Medical, Continuing | 1 | 2018 | 638 | 0.11 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Clinical Trials as Topic | 3 | 2020 | 7330 | 0.11 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.11 | Why? |
| Video Recording | 1 | 2017 | 786 | 0.11 | Why? |
| Delivery of Health Care | 1 | 2017 | 15909 | 0.11 | Why? |
| Antioxidants | 1 | 2020 | 1593 | 0.10 | Why? |
| Hydrocortisone | 1 | 2020 | 1790 | 0.10 | Why? |
| Noninvasive Ventilation | 3 | 2017 | 2329 | 0.10 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.10 | Why? |
| Animals | 6 | 2018 | 78931 | 0.10 | Why? |
| Immunization | 1 | 2019 | 2019 | 0.10 | Why? |
| Data Collection | 1 | 2019 | 1769 | 0.10 | Why? |
| Lung Injury | 1 | 2018 | 919 | 0.09 | Why? |
| Resource Allocation | 1 | 2020 | 1771 | 0.09 | Why? |
| Early Diagnosis | 1 | 2017 | 2443 | 0.09 | Why? |
| Delivery, Obstetric | 1 | 2018 | 1292 | 0.09 | Why? |
| Proteome | 1 | 2018 | 1812 | 0.09 | Why? |
| Evidence-Based Medicine | 2 | 2018 | 3228 | 0.09 | Why? |
| Oxygen | 2 | 2021 | 3715 | 0.09 | Why? |
| Treatment Outcome | 8 | 2021 | 51732 | 0.08 | Why? |
| Europe | 3 | 2021 | 12702 | 0.08 | Why? |
| Attitude to Health | 1 | 2020 | 2002 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Genomics | 1 | 2018 | 3118 | 0.08 | Why? |
| Contact Tracing | 3 | 2021 | 8448 | 0.08 | Why? |
| Lymphocytes | 1 | 2019 | 3056 | 0.07 | Why? |
| Consensus | 1 | 2020 | 6345 | 0.07 | Why? |
| Tracheostomy | 1 | 2018 | 1963 | 0.07 | Why? |
| Immunity, Cellular | 1 | 2017 | 3614 | 0.07 | Why? |
| Risk Factors | 6 | 2019 | 71621 | 0.07 | Why? |
| Intubation, Intratracheal | 2 | 2017 | 3962 | 0.07 | Why? |
| Anti-Inflammatory Agents | 2 | 2020 | 6153 | 0.07 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.07 | Why? |
| Severity of Illness Index | 7 | 2021 | 48226 | 0.07 | Why? |
| Male | 17 | 2021 | 367725 | 0.06 | Why? |
| Lung | 3 | 2021 | 31049 | 0.06 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.06 | Why? |
| Female | 16 | 2021 | 380317 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 2 | 2018 | 5002 | 0.06 | Why? |
| Length of Stay | 1 | 2019 | 11042 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2018 | 5150 | 0.06 | Why? |
| Cohort Studies | 6 | 2021 | 36005 | 0.06 | Why? |
| Adult | 13 | 2021 | 244371 | 0.05 | Why? |
| Respiratory Aspiration of Gastric Contents | 1 | 2019 | 8 | 0.05 | Why? |
| Ideal Body Weight | 1 | 2019 | 18 | 0.05 | Why? |
| Equivalence Trials as Topic | 1 | 2020 | 242 | 0.05 | Why? |
| Socioeconomic Factors | 1 | 2018 | 8495 | 0.05 | Why? |
| Cytoprotection | 1 | 2018 | 44 | 0.05 | Why? |
| Body Height | 1 | 2019 | 100 | 0.05 | Why? |
| Acute Kidney Injury | 1 | 2019 | 5762 | 0.05 | Why? |
| Feedback | 1 | 2021 | 317 | 0.05 | Why? |
| Culture Media, Conditioned | 1 | 2018 | 66 | 0.05 | Why? |
| Brachial Plexus | 1 | 2017 | 28 | 0.04 | Why? |
| beta-Glucans | 1 | 2020 | 176 | 0.04 | Why? |
| HSP70 Heat-Shock Proteins | 1 | 2018 | 113 | 0.04 | Why? |
| Matrix Metalloproteinases | 1 | 2018 | 131 | 0.04 | Why? |
| Coculture Techniques | 1 | 2018 | 258 | 0.04 | Why? |
| Aged | 9 | 2021 | 215776 | 0.04 | Why? |
| Early Termination of Clinical Trials | 1 | 2020 | 1256 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2020 | 757 | 0.04 | Why? |
| Tidal Volume | 1 | 2019 | 565 | 0.04 | Why? |
| Heart Failure | 1 | 2018 | 6638 | 0.04 | Why? |
| Comorbidity | 2 | 2019 | 34796 | 0.04 | Why? |
| Phagocytosis | 1 | 2018 | 409 | 0.04 | Why? |
| Macrophage Activation | 1 | 2018 | 315 | 0.04 | Why? |
| Protective Agents | 1 | 2018 | 250 | 0.04 | Why? |
| Incidence | 1 | 2018 | 25622 | 0.04 | Why? |
| Cannula | 1 | 2020 | 750 | 0.04 | Why? |
| Statistics, Nonparametric | 1 | 2018 | 1008 | 0.04 | Why? |
| Remission Induction | 1 | 2018 | 950 | 0.03 | Why? |
| Meta-Analysis as Topic | 1 | 2020 | 1289 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2020 | 1755 | 0.03 | Why? |
| Glomerular Filtration Rate | 1 | 2019 | 1262 | 0.03 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.03 | Why? |
| Creatinine | 1 | 2019 | 1443 | 0.03 | Why? |
| Multicenter Studies as Topic | 1 | 2020 | 2437 | 0.03 | Why? |
| Shock | 1 | 2020 | 1868 | 0.03 | Why? |
| Mexico | 1 | 2021 | 2787 | 0.03 | Why? |
| Cell Survival | 1 | 2018 | 1581 | 0.03 | Why? |
| Kinetics | 1 | 2021 | 3238 | 0.03 | Why? |
| Carbon Dioxide | 1 | 2019 | 917 | 0.03 | Why? |
| Organ Dysfunction Scores | 1 | 2018 | 1475 | 0.03 | Why? |
| Laryngoscopy | 1 | 2017 | 413 | 0.03 | Why? |
| Cell Differentiation | 1 | 2018 | 1338 | 0.03 | Why? |
| Postpartum Period | 1 | 2018 | 936 | 0.03 | Why? |
| Bayes Theorem | 1 | 2021 | 3237 | 0.03 | Why? |
| Plasma | 1 | 2021 | 1809 | 0.03 | Why? |
| Recombinant Proteins | 1 | 2021 | 3786 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Phosphoproteins | 1 | 2021 | 4346 | 0.03 | Why? |
| Alveolar Epithelial Cells | 1 | 2018 | 1445 | 0.03 | Why? |
| Computed Tomography Angiography | 1 | 2020 | 2153 | 0.03 | Why? |
| Recovery of Function | 1 | 2020 | 2461 | 0.02 | Why? |
| Propensity Score | 1 | 2018 | 2690 | 0.02 | Why? |
| Double-Blind Method | 1 | 2021 | 5988 | 0.02 | Why? |
| Immunomodulation | 1 | 2018 | 1472 | 0.02 | Why? |
| Pilot Projects | 1 | 2021 | 5182 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Canada | 1 | 2021 | 6018 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Membrane Proteins | 1 | 2018 | 1733 | 0.02 | Why? |
| Acute Disease | 1 | 2021 | 6029 | 0.02 | Why? |
| Analgesics, Opioid | 1 | 2017 | 1070 | 0.02 | Why? |
| Odds Ratio | 1 | 2019 | 5861 | 0.02 | Why? |
| Cesarean Section | 1 | 2018 | 2089 | 0.02 | Why? |
| Feasibility Studies | 1 | 2017 | 3467 | 0.02 | Why? |
| Immunotherapy | 1 | 2020 | 2421 | 0.02 | Why? |
| Diabetes Complications | 1 | 2018 | 2358 | 0.02 | Why? |
| Equipment Design | 1 | 2017 | 3095 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Quality Improvement | 1 | 2018 | 2435 | 0.02 | Why? |
| Internationality | 1 | 2018 | 3297 | 0.02 | Why? |
| France | 1 | 2021 | 12074 | 0.02 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.02 | Why? |
| Critical Illness | 2 | 2018 | 17281 | 0.02 | Why? |
| United States | 2 | 2021 | 46150 | 0.02 | Why? |
| Adrenal Cortex Hormones | 1 | 2020 | 6537 | 0.02 | Why? |
| Logistic Models | 1 | 2018 | 9089 | 0.02 | Why? |
| Spain | 1 | 2021 | 15545 | 0.02 | Why? |
| Mortality | 1 | 2019 | 7132 | 0.01 | Why? |
| Sex Factors | 1 | 2019 | 11014 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| United Kingdom | 1 | 2020 | 18046 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Aged, 80 and over | 2 | 2019 | 88759 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Diabetes Mellitus | 1 | 2018 | 8207 | 0.01 | Why? |
| Health Personnel | 1 | 2021 | 29646 | 0.01 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.01 | Why? |
| Antibodies, Viral | 1 | 2021 | 51949 | 0.01 | Why? |
| Young Adult | 1 | 2018 | 93724 | 0.01 | Why? |
Laffey's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(222)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(1357)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_